Inhibitory effects of glucosamine on endotoxin-induced uveitis in Lewis rats

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 12, 2008, Pages 5441-5449

  Chang, Yun Hsiang ^a   Horng, Chi Ting ^b,c   Chen, Yi Hao ^a   Chen, Po Liang ^a   Chen, Ching Long ^a   Liang, Chang Min ^d   Chien, Ming Wei ^d   Chen, Jiann Torng ^a,d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b Kaohsiung Armed Force General Hospital   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; ENDOTOXIN; GLUCOSAMINE SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; N ACETYLGLUCOSAMINE; NITRIC OXIDE; PROSTAGLANDIN; PROSTAGLANDIN E2; GLUCOSAMINE; LIPOPOLYSACCHARIDE; PTGS2 PROTEIN, RAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; AQUEOUS HUMOR; ARTICLE; CELL COUNT; CELL INFILTRATION; CILIARY BODY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INHIBITION KINETICS; IRIS; LEWIS RAT; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UVEITIS; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; CULTURE TECHNIQUE; IMMUNOLOGY; IRIDOCYCLITIS; METABOLISM; PATHOLOGY; SALMONELLA TYPHIMURIUM;

ANIMALS; AQUEOUS HUMOR; BLOTTING, WESTERN; CELL COUNT; CELL CULTURE TECHNIQUES; CILIARY BODY; CYCLOOXYGENASE 2; DINOPROSTONE; GLUCOSAMINE; INTERCELLULAR ADHESION MOLECULE-1; IRIS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED LEW; SALMONELLA TYPHIMURIUM; UVEITIS, ANTERIOR;

EID: 58149234576     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-1784     Document Type: Article

References (67)

1. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin-induced uveitis in rats as a model for human disease. Nature. 1980;286(5773):611-613. (Pubitemid 10015368)
2. Kogiso M, Tanouchi Y, Mimura Y, et al. Endotoxin-induced uveitis in mice, I: Induction of uveitis and role of T lymphocytes. Jpn J Ophthalmol. 1992;36(3):281-290.
3. Howes EL Jr, Aronson SB, McKay DG. Ocular vascular permeability: effect of systemic administration of bacterial endotoxin. Arch Ophthalmol. 1970;84(3):360-367.
4. Yoshida M, Yoshimura N, Hangai M, et al. Interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor gene expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1994;35(3):1107-1113. (Pubitemid 2045030)
5. de Vos AF, Klaren VN, Kijlstra A. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35(11):3873-3883. (Pubitemid 24334545)
6. de Vos AF, van Haren MA, Verhagen C, et al. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci. 1994;35(3):1100-1106. (Pubitemid 24079844)
7. Avunduk MC, Avunduk AM, Oztekin E, et al. Etanercept treatment in the endotoxin-induced uveitis of rats. Exp Eye Res. 2004;79(3):357-365. (Pubitemid 39164473)
8. Jacquemin E, de Kozak Y, Thillaye B, et al. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest Ophthalmol Vis Sci. 1996;37(6):1187-1196. (Pubitemid 26164248)
9. Bellot JL, Palmero M, Garcia-Cabanes C, et al. Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm Res. 1996;45(4):203-208. (Pubitemid 26135076)
10. Becker MD, Garman K, Whitcup SM, et al. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 2001;42(11):2563-2566. (Pubitemid 32954863)
11. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649-683. (Pubitemid 26130197)
12. Shishodia S, Aggarwal BB. Nuclear factor-κB: a friend or a foe in cancer? Biochem Pharmacol. 2004;68(6):1071-1080. (Pubitemid 39094272)
13. Li X, Stark GR. NFκB-dependent signaling pathways. Exp Hematol. 2002;30(4):285-296.
14. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol. 2002;3(3):221-227.
15. Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25(6):280-288. (Pubitemid 38610351)
16. O'Neill HC, Parish CR. Monosaccharide inhibition of cytotoxic T-cell function: demonstration of clone-specific effects. Immunology. 1988;64(1):181-184.
17. Yagita M, Nakajima M, Saksela E. Suppression of human natural killer cell activity by amino sugars. Cell Immunol. 1989;122(1):83-95. (Pubitemid 19199599)
18. Ma L, Rudert WA, Harnaha J, et al. Immunosuppressive effects of glucosamine. J Biol Chem. 2002;277(42):39343-39349.
19. Gouze JN, Bianchi A, Becuwe P, et al. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett. 2002;510(3):166-170. (Pubitemid 34093818)
20. Chen JT, Chen CH, Horng CT, et al. Glucosamine sulfate inhibits proinflammatory cytokine-induced icam-1 production in human conjunctival cells in vitro. J Ocul Pharmacol Ther. 2006;22(6):402-416. (Pubitemid 46106478)
21. Chen JT, Chen PL, Chang YH, et al. Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro. Exp Eye Res. 2006;83(5):1052-1062. (Pubitemid 44419401)
22. Chen JT, Liang JB, Chou CL, et al. Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 2006;47(2):664-672. (Pubitemid 46768396)
23. Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J Pharm Pharm Sci. 2002;5(2):181-184.
24. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol. 1997;29(6):867-870.
25. Madan B, Batra S, Ghosh B. 2′-Hydroxychalcone inhibits nuclear factor-κB and blocks tumor necrosis factor-alpha- and lipopolysaccharide- induced adhesion of neutrophils to human umbilical vein endothelial cells. Mol Pharmacol. 2000;58(3):526-534. (Pubitemid 30682992)
26. Liu SF, Ye X, Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation. 1999;100(12):1330-1337. (Pubitemid 29440127)
27. Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43(2):187-201.
28. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76(2):301-314.
29. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med. 2000;28(9):1379-1386. (Pubitemid 30623498)
30. Kanagawa T, Matsuda S, Mikawa Y, et al. Role of ICAM-1 and LFA-1 in endotoxin-induced uveitis in mice. Jpn J Ophthalmol. 1996;40(2):174-180. (Pubitemid 26290248)
31. Whitcup SM, Hikita N, Shirao M, et al. Monoclonal antibodies against CD54 (ICAM-1) and CD11a (LFA-1) prevent and inhibit endotoxin-induced uveitis. Exp Eye Res. 1995;60(6):597-601.
32. Yang P, de Vos AF, Kijlstra A. Interferon gamma immunoreactivity in iris nerve fibres during endotoxin induced uveitis in the rat. Br J Ophthalmol. 1998;82(6):695-699. (Pubitemid 28306663)
33. Whitcup SM, Chan CC, Li Q, Nussenblatt RB. Expression of cell adhesion molecules in posterior uveitis. Arch Ophthalmol. 1992;110(5):662-666.
34. Grakoui A, Bromley SK, Sumen C, et al. The immunological synapse: a molecular machine controlling T cell activation. Science. 1999;285(5425):221- 227. (Pubitemid 29329988)
35. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87(1):13-20.
36. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokineinducible enhancers. FASEB J. 1995;9(10):899-909.
37. Sahnoun Z, Jamoussi K, Zeghal KM. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)]. Therapie. 1998;53(4):315-339.
38. Alberts B, Johnson A, Lewis J, et al. The activation of a macrophage by LPS. In: Molecular Biology of the Cell. 4th ed. London: Garland Science; 2002:1458.
39. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993;362(6417):248-250. (Pubitemid 23093630)
40. Doherty TM, Kastelein R, Menon S, et al. Modulation of murine macrophage function by IL-13. J Immunol. 1993;151(12):7151-7160. (Pubitemid 24001089)
41. Marie O, Thillaye-Goldenberg B, Naud MC, de Kozak Y. Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13. Invest Ophthalmol Vis Sci. 1999;40(10):2275-2282. (Pubitemid 29418382)
42. Cosentino G, Soprana E, Thienes CP, et al. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol. 1995;155(6):3145-3151.
43. Di Santo E, Meazza C, Sironi M, et al. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J Immunol. 1997;159(1):379-382. (Pubitemid 127493722)
44. Lemaitre C, Thillaye-Goldenberg B, Naud MC, de Kozak Y. The effects of intraocular injection of interleukin-13 on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2001;42(9):2022-2030. (Pubitemid 32726034)
45. Yang P, de Vos AF, Kijlstra A. Macrophages in the retina of normal Lewis rats and their dynamics after injection of lipopolysaccharide. Invest Ophthalmol Vis Sci. 1996;37(1):77-85. (Pubitemid 26036519)
46. Kamata K, Inazu M, Takeda H, et al. Effect of a selective inducible nitric oxide synthase inhibitor on intraocular nitric oxide production in endotoxin-induced uveitis rabbits: in vivo intraocular microdialysis study. Pharmacol Res. 2003;47(6):485-491. (Pubitemid 36542927)
47. Tilton RG, Chang K, Corbett JA, et al. Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production. Invest Ophthalmol Vis Sci. 1994;35(8):3278-3288. (Pubitemid 24241366)
48. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157(1):87-94. (Pubitemid 19004828)
49. Goureau O, Bellot J, Thillaye B, et al. Increased nitric oxide production in endotoxin-induced uveitis: reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol. 1995;154(12):6518-6523.
50. Mandai M, Yoshimura N, Yoshida M, et al. The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. Invest Ophthalmol Vis Sci. 1994;35(10):3673-3680. (Pubitemid 24337980)
51. Cao C, Matsumura K, Yamagata K, Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain: its possible role in the febrile response. Brain Res. 1995;697(1-2):187-196.
52. Quan N, Whiteside M, Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res. 1998;802(1-2):189-197. (Pubitemid 28392171)
53. Lee SH, Soyoola E, Chanmugam P, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem. 1992;267(36):25934-25938. (Pubitemid 23013998)
54. Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and non-ulcerogenic. Proc Natl Acad Sci U S A. 1994;91(8):3228-3232.
55. Seibert K, Zhang Y, Leahy K, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A. 1994;91(25):12013-12017. (Pubitemid 24368594)
56. Smith JR, Hart PH, Williams KA. Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol. 1998;76(6):497-512.
57. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem. 1994;269(7):4705-4708. (Pubitemid 24239438)
58. Noh EJ, Ahn KS, Shin EM, et al. Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-κB activation in RAW 264.7 macrophages. Life Sci. 2006;79(7):695-701. (Pubitemid 43927982)
59. Altman RD, Lozada CJ. Practice guidelines in the management of osteoarthritis. Osteoarthritis Cartilage. 1998;6(suppl A):22-24.
60. Pavelka K, Gatterova J, Gollerova V, et al. A 5-year randomized controlled, double-blind study of glycosaminoglycan polysulphuric acid complex (Rumalon) as a structure modifying therapy in osteoarthritis of the hip and knee. Osteoarthritis Cartilage. 2000;8(5):335-342. (Pubitemid 30707520)
61. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357(9252):251-256. (Pubitemid 32120855)
62. Muller-Fassbender H, Bach GL, Haase W, et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994;2(1):61-69. (Pubitemid 24159681)
63. Largo R, Alvarez-Soria MA, Diez-Ortego I, et al. Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2003;11(4):290-298. (Pubitemid 36410882)
64. Shikhman AR, Kuhn K, Alaaeddine N, Lotz M. N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J Immunol. 2001;166(8):5155-5160. (Pubitemid 32280730)
65. Homandberg GA, Wen C, Hui F. Agents that block fibronectin fragment-mediated cartilage damage also promote repair. Inflamm Res. 1997;46(11):467-471. (Pubitemid 27507609)
66. Bekesi JG, Winzler RJ. The effect of D-glucosamine on the adenine and uridine nucleotides of sarcoma 180 ascites tumor cells. J Biol Chem. 1969;244(20):5663-5668.
67. Monauni T, Zenti MG, Cretti A, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes. 2000;49(6):926-935. (Pubitemid 30349414)